Jing Zhao1, Hui Wu, Lan Zheng, Yingfeng Weng, Yanqing Mo. 1. Department of Neurology, Minhang District Central Hospital, 170 Xinsong Road, Shanghai 201100, China. Electronic address: zhaojingssmu@163.com.
Abstract
BACKGROUND AND PURPOSE: Recovery after stroke varies considerably between individuals. An abundance of evidence suggests that genetic factors contribute to stroke recovery. The aim of this study was to determine whether or not the BDNF G196A polymorphism independently influences the occurrence, severity, and 90-day functional outcome in Chinese patients with ischemic stroke (IS). METHODS: BDNF G196A genetic variants were investigated in 494 IS and 346 controls. Severity was assessed by the National Institutes of Health Stroke Scale at the time of admission. Three hundred and eight patients were assessed 90 days post-stroke using the Modified Rankin Scale to determine stroke outcome. RESULTS: We showed that a significant association existed between the BDNF G196A AA genotype and the occurrence of IS (P=0.021), even after adjustment for covariates (P=0.028). The AA genotype of the BDNF G196A was associated with a poor outcome of recovery 3 months after stroke onset (P=0.008) was a novel finding, independent of other known predictors of poor outcome (P=0.012). CONCLUSIONS: The BDNF G196A polymorphism was significantly associated with the occurrence and long-term outcomes of IS, thus BDNF G196A may be used as a prognostic biomarker and therapeutic target in IS.
BACKGROUND AND PURPOSE: Recovery after stroke varies considerably between individuals. An abundance of evidence suggests that genetic factors contribute to stroke recovery. The aim of this study was to determine whether or not the BDNFG196A polymorphism independently influences the occurrence, severity, and 90-day functional outcome in Chinese patients with ischemic stroke (IS). METHODS:BDNFG196A genetic variants were investigated in 494 IS and 346 controls. Severity was assessed by the National Institutes of Health Stroke Scale at the time of admission. Three hundred and eight patients were assessed 90 days post-stroke using the Modified Rankin Scale to determine stroke outcome. RESULTS: We showed that a significant association existed between the BDNFG196A AA genotype and the occurrence of IS (P=0.021), even after adjustment for covariates (P=0.028). The AA genotype of the BDNFG196A was associated with a poor outcome of recovery 3 months after stroke onset (P=0.008) was a novel finding, independent of other known predictors of poor outcome (P=0.012). CONCLUSIONS: The BDNFG196A polymorphism was significantly associated with the occurrence and long-term outcomes of IS, thus BDNFG196A may be used as a prognostic biomarker and therapeutic target in IS.
Authors: Tara M Stanne; Anna Tjärnlund-Wolf; Sandra Olsson; Katarina Jood; Christian Blomstrand; Christina Jern Journal: PLoS One Date: 2014-12-03 Impact factor: 3.240
Authors: Christine T Shiner; Kerrie D Pierce; Angelica G Thompson-Butel; Terry Trinh; Peter R Schofield; Penelope A McNulty Journal: Front Neurol Date: 2016-05-17 Impact factor: 4.003
Authors: Wei He; Peng Huang; Dinghua Liu; Lingling Zhong; Rongbin Yu; Jianan Li Journal: Int J Environ Res Public Health Date: 2016-10-17 Impact factor: 3.390
Authors: Ansley Stanfill; Claire Simpson; Paula Sherwood; Samuel Poloyac; Elizabeth Crago; Hyungsuk Kim; Yvette Conley Journal: SAGE Open Med Date: 2017-08-31